Inozyme Pharma, Inc
Inozyme Pharma, Inc., located in Boston, MA, focuses on developing innovative therapies for rare genetic disorders, specifically targeting conditions such as ENPP1 and ABCC6 deficiencies. Now a wholly owned subsidiary of BioMarin Pharmaceutical Inc., the company is dedicated to translating genetic discoveries into life-improving medications for patients.
Through a commitment to research, clinical trials, and patient engagement, Inozyme Pharma seeks to provide hope and solutions for individuals affected by rare diseases. Their pioneering efforts are complemented by a collaborative environment and a passionate team striving to enhance the quality of life for patients and families in need.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

